Casdin Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
|
|||||
|
2025
Q1 | $57.5M | Sell |
|
|||||
|
2024
Q4 | $131M | Hold |
|
|||||
|
2024
Q3 | $134M | Hold |
|
|||||
|
2024
Q2 | $170M | Buy |
|
|||||
|
2024
Q1 | $138M | Buy |
|
|||||
|
2023
Q4 | $97.1M | Sell |
|
|||||
|
2023
Q3 | $122M | Sell |
|
|||||
|
2023
Q2 | $116M | Sell |
|
|||||
|
2023
Q1 | $160M | Sell |
|
|||||
|
2022
Q4 | $170M | Buy |
|
|||||
|
2022
Q3 | $135M | Buy |
|
|||||
|
2022
Q2 | $48.7M | Sell |
|
|||||
|
2022
Q1 | $62.5M | Sell |
|
|||||
|
2021
Q4 | $122M | Buy |
|
|||||
|
2021
Q3 | $102M | Buy |
|
|||||
|
2021
Q2 | $68.8M | Buy |
|
|||||
|
2021
Q1 | $41M | Buy |
|
|||||
|
2020
Q4 | $90.4M | Hold |
|
|||||
|
2020
Q3 | $74.4M | Hold |
|
|||||
|
2020
Q2 | $85M | Sell |
|
|||||
|
2020
Q1 | $65.5M | Hold |
|
|||||
|
2019
Q4 | $86.5M | Sell |
|
|||||
|
2019
Q3 | $66.3M | Buy |
|
|||||
|
2019
Q2 | $50.9M | Buy |
|
|||||
|
2019
Q1 | $36.4M | Buy |
|
|||||
|
2018
Q4 | $16.4M | Buy |
|
|||||
|
2018
Q3 | $6.46M | Buy |
|